Fulcrum Therapeutics's total assets for Q1 2025 were $228.84M, a decrease of -5.69% from the previous quarter. FULC total liabilities were $14.46M for the fiscal quarter, a 2.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.